179 related articles for article (PubMed ID: 16544042)
1. [Congenital adrenal hyperplasia newborn screening: Rio de Janeiro experience].
Cardoso CB; Fonseca AA; Oliveira Mde F; Pereira BB; Guimarães MM
Arq Bras Endocrinol Metabol; 2005 Feb; 49(1):112-9. PubMed ID: 16544042
[TBL] [Abstract][Full Text] [Related]
2. Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol.
Miller WL
Horm Res Paediatr; 2019; 91(6):416-420. PubMed ID: 31450227
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of CYP21A2 can optimize the follow-up of positive results in newborn screening for congenital adrenal hyperplasia.
Silveira EL; Elnecave RH; dos Santos EP; Moura V; Pinto EM; van der Linden Nader I; Mendonca BB; Bachega TA
Clin Genet; 2009 Dec; 76(6):503-10. PubMed ID: 19930153
[TBL] [Abstract][Full Text] [Related]
4. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
[TBL] [Abstract][Full Text] [Related]
5. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia.
Hayashi G; Faure C; Brondi MF; Vallejos C; Soares D; Oliveira E; Brito VN; Mendonca BB; Bachega TA
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):632-7. PubMed ID: 22218447
[TBL] [Abstract][Full Text] [Related]
6. Neonatal screening for congenital adrenal hyperplasia: experience and results in Argentina.
Gruñieiro-Papendieck L; Chiesa A; Mendez V; Prieto L
J Pediatr Endocrinol Metab; 2008 Jan; 21(1):73-8. PubMed ID: 18404975
[TBL] [Abstract][Full Text] [Related]
7. Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency.
Tonetto-Fernandes V; Lemos-Marini SH; Kuperman H; Ribeiro-Neto LM; Verreschi IT; Kater CE
J Clin Endocrinol Metab; 2006 Jun; 91(6):2179-84. PubMed ID: 16551734
[TBL] [Abstract][Full Text] [Related]
8. Neonatal screening for congenital adrenal hyperplasia.
Barra CB; Silva IN; Pezzuti IL; Januário JN
Rev Assoc Med Bras (1992); 2012; 58(4):459-64. PubMed ID: 22930025
[TBL] [Abstract][Full Text] [Related]
9. Ten-year evaluation of a Neonatal Screening Program for congenital adrenal hyperplasia.
Nascimento ML; Cristiano AN; Campos Td; Ohira M; Cechinel E; Simoni G; Lee Jv; Linhares RM; Silva PC
Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):765-71. PubMed ID: 25372587
[TBL] [Abstract][Full Text] [Related]
10. [Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
Cattani A; Reyes ML; Azócar M; Soto J; Romeo E; Valdivia L; Poggi H; Foradori A
Rev Med Chil; 2000 Oct; 128(10):1113-8. PubMed ID: 11349510
[TBL] [Abstract][Full Text] [Related]
11. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
[TBL] [Abstract][Full Text] [Related]
12. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
Hayashi GY; Carvalho DF; de Miranda MC; Faure C; Vallejos C; Brito VN; Rodrigues AS; Madureira G; Mendonca BB; Bachega TA
Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
[TBL] [Abstract][Full Text] [Related]
13. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.
Therrell BL; Berenbaum SA; Manter-Kapanke V; Simmank J; Korman K; Prentice L; Gonzalez J; Gunn S
Pediatrics; 1998 Apr; 101(4 Pt 1):583-90. PubMed ID: 9521938
[TBL] [Abstract][Full Text] [Related]
14. Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance.
Votava F; Novotna D; Kracmar P; Vinohradska H; Stahlova-Hrabincova E; Vrzalova Z; Neumann D; Malikova J; Lebl J; Matern D
Eur J Pediatr; 2012 Jun; 171(6):935-40. PubMed ID: 22234478
[TBL] [Abstract][Full Text] [Related]
15. Influence of spironolactone on neonatal screening for congenital adrenal hyperplasia.
Terai I; Yamano K; Ichihara N; Arai J; Kobayashi K
Arch Dis Child Fetal Neonatal Ed; 1999 Nov; 81(3):F179-83. PubMed ID: 10525019
[TBL] [Abstract][Full Text] [Related]
16. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
Allen DB; Hoffman GL; Fitzpatrick P; Laessig R; Maby S; Slyper A
J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
[TBL] [Abstract][Full Text] [Related]
17. 3β-hydroxysteroid dehydrogenase type II deficiency on newborn screening test.
Araújo VG; Oliveira RS; Gameleira KP; Cruz CB; Lofrano-Porto A
Arq Bras Endocrinol Metabol; 2014 Aug; 58(6):650-5. PubMed ID: 25211449
[TBL] [Abstract][Full Text] [Related]
18. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
Castro PS; Rassi TO; Araujo RF; Pezzuti IL; Rodrigues AS; Bachega TASS; Silva IN
J Pediatr Endocrinol Metab; 2019 May; 32(5):499-504. PubMed ID: 31028712
[TBL] [Abstract][Full Text] [Related]
19. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
Pezzuti IL; Barra CB; Mantovani RM; Januário JN; Silva IN
J Pediatr (Rio J); 2014; 90(3):300-7. PubMed ID: 24560529
[TBL] [Abstract][Full Text] [Related]
20. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome.
Maffazioli GDN; Bachega TASS; Hayashida SAY; Gomes LG; Valassi HPL; Marcondes JAM; Mendonca BB; Baracat EC; Maciel GAR
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32530459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
